Verthermia, Inc. has selected the eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer. For more information, read Merge’s press release.Read more
Verthermia has developed a procedure to treat cancer using heat, replicating the body’s natural defense against disease.
This technique of initiating an artificial fever creates a cytotoxic environment for cancer cells while leaving normal healthy cells unharmed.
Los Gatos, Calif. (Oct. 27, 2014) – In January, 2014 Verthermia, Inc. obtained clearance from FDA and began a Phase I clinical trial exploring the potential of whole body hyperthermia (WBH) as a standalone treatment for Stage III or IV ovarian cancer. The company has completed eight treatments as of October, 2014. The use of heat ...Read more